Living the science, delivering the promise
Our four global hubs represent key markets for EMD Serono, better positioning the organization to deliver high-quality biopharmaceutical products to patients around the world. Our commitment to this goal is clear: each year, EMD Serono invests roughly 20% of total sales in R&D to strengthen the future of our organization.
Our research and development activities are built on a foundation of expertise in neurology, immunology, immuno-oncology and oncology. With close collaboration across the R&D teams, EMD Serono is strengthening its synergies to discover and advance innovative therapies that address high medical needs.
This center of excellence in R&D is designed to attract the very best scientific talent and underpin a broad range of partnerships with US-based companies, academic centers and key opinion leaders, especially in Boston where the life sciences community is exceptionally strong.
The state-of-the-art Billerica facility is now home to approximately 200 scientists and more than 150 clinical development professionals.
The people behind the research
Tapping into the creativity of the best scientific minds is the key to EMD Serono's innovation strategy.
> Scientist Profiles